Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a single-arm phase 2 study of the ...
Nimotuzumab combined with chemotherapy in the first-line treatment for patients with stage IVB, recurrent or persistent cervical squamous cell carcinoma: A multi ...
TipRanks on MSN
Akeso’s Phase II Study on AK104: A Potential Game-Changer for Vulvar Cancer Treatment
Akeso, Inc. (($HK:9926)) announced an update on their ongoing clinical study. Akeso, Inc. is conducting a multicenter, open-label, Phase II study ...
18hon MSN
Unheard. Unserved: Misdiagnosed for years, terminal cancer patient says more access could save lives
The 45-year-old mother of two says the hardest aspect of her vulvar cancer diagnosis has been coming to terms with leaving ...
Vulvar and cervical cancers affect thousands of women each year, particularly in low and middle-income countries. In 2022, the World Health Organization estimated that about 94% of the deaths caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback